Walgreens MedMonitor® Complete Reduces Total Health Care Costs with a 3.7 and 7.8 ROI
Walgreens Health Services (NYSE: WAG)(NASDAQ: WAG) has announced the launch of its new prescription utilization management program, MedMonitor® Complete. This industry-leading holistic utilization management program is designed to help promote pharmacy benefit and total health care cost-containment. The proprietary clinical program is comprised of two components, MedMonitor®XR and MedMonitor®24, that have demonstrated cost savings for payors and their members.
MedMonitor Complete uses a state-of-the-art patient-matching process to provide a single clinical view of a patient and maintains their claims history, even if they’ve changed their name, employer group or cardholder identification number. The program integrates prescription and medical claims to review an entire population and identify patients’ risks for adverse drug events and nonadherence to clinically appropriate standards of therapy. Specialized clinical pharmacists communicate directly with the patient and/or the patients’ health care professionals to notify them of medication-related problems such as over- or under-utilization, or opportunities to benefit from additional therapy. This process effectively minimizes patient disruption while arming health care professionals with the necessary information to improve patient care.
MedMonitorXR is the next-generation medication therapy management program. For a 26,000-life commercial group, a 3.7-to-1 return on investment was realized with the polypharmacy option, which resulted in a $54 per member per month savings for intervened patients. MedMonitorXR, a program for targeted patients with targeted care, offers four intervention opportunities: polypharmacy, appropriateness of therapy, compliance and persistency and inappropriate medications in the elderly. MedMonitorXR assists payors by focusing on the highest utilizers of prescription medication. Typically, 3 to 5.5 percent of commercial, Medicare or retiree populations account for 32 to 42 percent of a payor’s drug spend.
MedMonitor24 completes this approach to holistic care by monitoring every prescription, every day for an entire population to help prevent members from reaching the at-risk group. This daily medication evaluation program demonstrated an impressive return on investment of 7.8-to-1 for participating clients. Thirty-one percent of interventions sent to health care providers, including pharmacies, resulted in the recommended changes to medication therapy.
MedMonitor Complete also enhances a payor’s formulary management strategies. The program’s outcomes are based on total health care savings, which include both prescription and medical savings for each client. These interventions produce savings for payors and their members.
“Our goal with MedMonitor Complete is to provide health care professionals the most clinically relevant information that yields the greatest impact,” explained Jim Langman, Walgreens vice president of clinical services. “The program’s impact calculations are pure - not artificially inflated with brand-to-generic conversions, step therapies and prior authorizations. Our results are fully transparent. Benefit managers can clearly see reduced cost and positive health outcomes for their members.”
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.